This announcement is a separate document:
科研製薬：[遅延] [概要] 2023年度第1四半期の連結財務結果
Kaken Pharmaceutical: [Delayed][Summary]Consolidated Financial Results for the First Quarter of Fiscal 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.